The observed differences, especially in case of tumor cells, may result from the mutations and epigenetic changes leading to the modifications in the expression of enzymes such as catalase or superoxide dismutase and in intracellular glutathione pool which are the main players in the regulation of ROS level. The gene discussed is CAT; the disease is neoplasm.